(February 2010)
The new resource comes as GLP-1 medications have become increasingly popular for weight loss
Further evidence of hemodynamic benefit is suggested by a recent mediation analysis from EMPA-REG showing that markers of plasma volume such as hematocrit and hemoglobin were important markers associated with reduction in cardiovascular mortality observed with SGLT2i use (10,78)
Ali ES, Hua J, Wilson CH, Tallis GA, Zhou FH, Rychkov GY, et al
That is not a comprehensive model of care
Emerging evidence suggests they may exert anabolic effects on bone, mitigate skeletal damage associated with obesity and diabetes, promote wound healing, and reduce perioperative complications